These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2418464)

  • 21. Interleukin 2: a review.
    Kolitz JE; Welte K; Sykora KW; Mertelsmann R
    Arzneimittelforschung; 1985; 35(10):1607-15. PubMed ID: 3000391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphokine synthesis is induced in human thymocytes by activation of the CD 2 (T11) pathway.
    Reem GH; Carding S; Reinherz EL
    J Immunol; 1987 Jul; 139(1):130-4. PubMed ID: 2438347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 2 acts directly on a Tac-positive cloned B cell line established from a patient with adult T cell leukemia.
    Arima N; Daitoku Y; Hidaka S; Tanaka H; Katsuki T
    J Immunol; 1985 Oct; 135(4):2474-7. PubMed ID: 2863306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
    Van Wauwe JP; Goossens JG; Beverley PC
    J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro cultivation of normal and neoplastic human T lymphocytes.
    Markham PD; Salahuddin SZ; Gallo RC
    Clin Haematol; 1984 Jun; 13(2):423-46. PubMed ID: 6088144
    [No Abstract]   [Full Text] [Related]  

  • 30. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
    Kurki P; Lotz M; Ogata K; Tan EM
    J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA; Tsudo M
    Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multichain interleukin-2 receptor: from the gene to the bedside.
    Waldmann TA
    Harvey Lect; 1986-1987; 82():1-17. PubMed ID: 3129378
    [No Abstract]   [Full Text] [Related]  

  • 33. Urokinase receptor. An activation antigen in human T lymphocytes.
    Nykjaer A; Møller B; Todd RF; Christensen T; Andreasen PA; Gliemann J; Petersen CM
    J Immunol; 1994 Jan; 152(2):505-16. PubMed ID: 8283034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.
    Reed JC; Tadmori W; Kamoun M; Koretzky G; Nowell PC
    J Immunol; 1985 Mar; 134(3):1631-9. PubMed ID: 2981917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T-cell growth factor (TCGF).
    Sarin PS; Gallo RC
    Crit Rev Immunol; 1984; 4(4):279-305. PubMed ID: 6232114
    [No Abstract]   [Full Text] [Related]  

  • 37. Two pathways of T cell activation.
    Meuer SC; Hauer M; Deusch K; Moebius U; Meyer zum Büschenfelde KH
    Behring Inst Mitt; 1987 Jun; (81):15-30. PubMed ID: 3115246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism.
    Brown M; Hu-Li J; Paul WE
    J Immunol; 1988 Jul; 141(2):504-11. PubMed ID: 3133410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.